Written and maintained by CASRAI Editorial Board
Last updated
Deadstock is inventory that hasn’t moved in long enough that it’s no longer realistic to plan around — it’s still on the shelf, still tying up storage and working capital, but it’s not part of the normal reorder cycle anymore. That’s different from a temporary overstock that will clear on its own next ordering cycle, and the distinction matters: most of what looks like a deadstock problem is actually a par level problem caught late. The earlier a facility separates the two, the more disposition options it still has before an item becomes a total write-off.
This guide covers where obsolete medical supply stock actually comes from and the practical ways to move it before it’s worthless — return to the vendor where policy allows, donation with proper documentation, or a discounted internal transfer to a department or site that can still use it. It doesn’t repeat CASRAI’s existing par level or donated-equipment guides — it cross-links both and focuses on the piece they don’t cover: catching an item on its way to obsolescence and choosing the right exit before it’s an automatic write-off.
How stock actually goes obsolete
Three causes account for most deadstock in a medical supply operation, and they call for different fixes.
Over-ordering against par level
A par level set too high — or a bulk order taken to hit a vendor’s minimum order quantity or a volume price break — brings in more units than actual usage will clear before the item’s relevance or shelf life runs out. This is the most preventable of the three causes, because it’s created at the ordering decision itself rather than by something external changing. A facility that reviews par levels against trailing usage on a fixed cadence, rather than only when someone notices a shelf is full, catches this before the surplus becomes deadstock rather than after.
A protocol or product change makes the item obsolete
Usage can also stop for reasons that have nothing to do with how much was ordered. A clinical guideline update drops a product from the standard of care. A vendor is switched under a group purchasing contract and the old brand’s disposables no longer fit the new equipment. A device is recalled, or a manufacturer discontinues a SKU and the remaining stock has no compatible replacement use. In these cases the units on the shelf are fine — nothing is wrong with them physically — but demand for them has been cut off at the source, and no amount of reorder-cadence discipline would have prevented it. The signal to watch for is a SKU whose usage drops to near zero abruptly rather than gradually; that pattern points to an external cause, not a forecasting miss, and it’s worth confirming with whoever owns the clinical or purchasing decision before assuming the stock is simply slow.
Expiry outrunning usage
Low-turn, fixed-shelf-life items — a seasonal supply, a specialty kit stocked for a procedure done a few times a year, a reagent or sterile item with a shorter dating than the rest of the catalog — can be moving at a perfectly normal rate and still expire before the case volume catches up. This is different from the first two causes because the order quantity and the demand signal can both have been reasonable; the shelf life was just shorter than the usage cycle. Strict first-expired-first-out picking discipline slows this down but can’t fully prevent it for genuinely low-frequency items — some amount of expiry-driven loss on the slowest-moving SKUs is close to structural, and the goal shifts from prevention to catching it with enough runway left to use one of the disposition options below instead of losing the units outright.
The disposition ladder, before write-off
All three causes produce the same asset — units sitting on a shelf with no near-term buyer inside the normal reorder cycle — and the same three exits apply regardless of which cause created it. The order below is roughly the order to check them in: return recovers the most value, donation recovers documented goodwill and, in some cases, a tax benefit, and internal transfer at least keeps the unit in clinical use somewhere in the organization. Write-off is what’s left once none of the three actually apply.
Return to vendor, where policy allows
Return-to-vendor is worth checking first because it’s the only option that can recover actual purchase value rather than just avoiding a total loss. It’s also the most conditional: most distributors only accept returns on unopened, unexpired, resalable stock within a defined window from the invoice date, and many charge a restocking fee against whatever they do refund. Special-order items, controlled substances, and anything temperature-sensitive or already outside its shelf-stable window are typically excluded outright, and a vendor relationship that’s been used for return requests repeatedly can affect how flexibly future requests are handled. CASRAI’s guide to reading a vendor’s return and restocking policy covers what to check in the contract before assuming an item is returnable — read that before contacting the vendor rather than finding out the item doesn’t qualify after the request is already in.
Donation, with proper documentation
Where the item is still within date, unopened, and return isn’t available or doesn’t clear the full quantity, donation to a nonprofit clinic or a medical surplus-recovery organization is usually the next best option — it keeps the unit in clinical use and, for a facility organized as a C corporation, an inventory donation to a qualifying charity can carry an enhanced deduction under Internal Revenue Code §170(e)(3), separate from whatever recovery the facility itself gets. The documentation burden is the real cost of this route, not the logistics: the recipient needs a clean chain of custody, an explicit record of remaining shelf life at the time of transfer, and confirmation the item was never expired at any point in the chain, since an expired unit reaching a patient-facing recipient is a liability problem for both sides, not just a paperwork gap. CASRAI’s donated and used equipment guide covers what that documentation needs to include and how a receiving clinic should evaluate what’s offered to it — this section only covers the donor-side decision to route deadstock there instead of writing it off.
Discounted internal transfer between departments or sites
For a multi-department or multi-site organization, the fastest exit is often internal: a department or facility with genuinely higher usage of the same SKU takes it at a reduced internal transfer price rather than the originating department eating a full write-off. This works best where a shared central stores function or a visible cross-department inventory system already exists, since the whole option depends on someone outside the originating unit actually knowing the stock is available before it expires — a transfer offer made after the fact, once the item is already near its dating limit, converts a real option into a race against the clock. Building a standing habit of flagging slow-moving stock to central stores or a shared inventory list on a fixed schedule, rather than only when a department notices its own overstock, is what keeps this option genuinely available rather than theoretical.
When it’s genuinely a write-off
None of the three routes above work for stock that’s expired, subject to a recall, or was never eligible for one of them to begin with (final-sale, controlled substance, or already outside its usable window at the point it was flagged). That’s a legitimate write-off, not a process failure — the goal of catching deadstock early isn’t to eliminate write-offs entirely, it’s to make sure the only stock that ends up written off is the stock genuinely past its options, not stock that could have been returned, donated, or transferred if someone had looked at it a few months sooner. CASRAI’s asset disposal policy guide covers what a defensible disposal record needs to include once an item reaches that point.
Reducing how much deadstock accumulates in the first place
The three causes above point to three habits that keep the volume down without eliminating it entirely: reviewing par levels against trailing usage on a fixed schedule rather than reactively; routing any protocol, formulary, or vendor change through a check of what stock it strands before the change takes effect, not after; and applying strict first-expired-first-out picking on the SKUs with the shortest shelf life relative to their usage rate. None of these fully prevent deadstock — some is close to structural for genuinely low-frequency items — but together they shrink the volume that ever needs one of the disposition options above, and they widen the window in which return, donation, and internal transfer are all still realistically available.
Frequently asked questions
What’s the difference between deadstock and normal overstock?
Overstock is inventory above the immediate reorder point that’s still expected to clear within the normal usage cycle — it’s a timing issue, not a disposition problem. Deadstock is stock that’s fallen out of the normal reorder cycle entirely, usually because usage stopped (a protocol or vendor change) or because the shelf-life window is closing faster than usage can clear the quantity on hand. The practical test is whether the item still appears in a routine reorder forecast; if it doesn’t, it’s deadstock, not overstock.
Can expired medical supplies be donated?
No. Reputable receiving organizations require confirmation that donated medical supplies are within date and were never expired at any point in the chain of custody — passing along an expired unit is a liability exposure for the donor and the recipient, not a way to avoid a write-off. Donation only works as a disposition option while the item still has usable shelf life remaining; once it expires, disposal is the only route left.
Do vendors always accept returns on unused medical supplies?
No — return eligibility depends on the vendor’s own policy, and it’s typically limited to unopened, unexpired, resalable stock within a defined window from the invoice date, often with a restocking fee deducted from the refund. Special-order items, controlled substances, and temperature-sensitive products are commonly excluded outright. Check the specific contract or distributor policy before assuming an item qualifies.
How do departments actually coordinate an internal transfer of excess stock?
It requires a shared visibility mechanism — a central stores function, a shared inventory system, or even a standing routine of flagging slow-moving SKUs to other departments on a fixed schedule — so a department with higher usage of the same item can claim it before it expires. Without that visibility, the option exists in theory but rarely happens in practice, because the originating department has no way to know who else might want the stock before it’s too late to move it.
